2024年8月，国际知名学术期刊《Cureus》上发表的一项临床病例报告，详细记录了一位61岁晚期肝细胞癌患者在接受联合NK细胞治疗方案（DC疫苗+NK细胞+纳武利尤单抗）后，病情得到显著改善。其中，肝脏储备功能显著改善，肝部肿瘤体积大幅减小，为后续 ...

Investigators have demonstrated the role of allogeneic NK cell therapy in the treatment of various malignancies. Techniques for ex vivo expansion and refinement in the administration of ...

Anti-KIR blocking antibodies has led to important therapeutic implications in NK cell immunotherapy. 1-7F9 is a human monoclonal antibody that cross reacts with KIR2DL-1, -2, -3 and prevents their ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

“We connect NK cells with tumor cells so they can destroy ... Innate Pharma’s therapies mark the dawn of a new generation of immunotherapy agents. “For the last 10 years, I think ...

To assess whether NK cells were involved in antitumor response generated by fasting, Delconte and her team depleted these ...

2025 年 2 月 10 日，中国科学技术大学生命科学与医学部、免疫应答与免疫治疗全国重点实验室王毅课题组在 Cell 子刊 Molecular Therapy 在线发表了题为“ A BPTF-specific PROTAC degrader enhances NK cell-based cancer immunotherapy ” 的研究论文 ...

Discover how leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

Prof. MENG Guangxun's team from the Shanghai Institute of Immunity and Infection of the Chinese Academy of Sciences, and collaborators, have revealed a novel mechanism whereby a short form of IL-18, ...

Get Instant Summarized Text (Gist) A new strategy using genetically modified natural killer (NK) cells has been developed to target HIV-positive cells. By expressing CD64, these NK cells can hold ...

New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.